Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/amend-clinical-trial-rules-after-wider-consultations-health-activists-12545/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/amend-clinical-trial-rules-after-wider-consultations-health-activists-12545/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/amend-clinical-trial-rules-after-wider-consultations-health-activists-12545/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/amend-clinical-trial-rules-after-wider-consultations-health-activists-12545/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6817f23d74574-trace').style.display = (document.getElementById('cakeErr6817f23d74574-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr6817f23d74574-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6817f23d74574-code').style.display = (document.getElementById('cakeErr6817f23d74574-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr6817f23d74574-context').style.display = (document.getElementById('cakeErr6817f23d74574-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr6817f23d74574-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr6817f23d74574-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 12425,
		&#039;title&#039; =&gt; &#039;Amend clinical trial rules after wider consultations: health activists&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
-The Hindu
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Issues of conflict of interest within Ethics Committee remain to be resolved, they say
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Public health activists and women&#039;s rights groups have raised concerns over compensation-related amendments to the Drugs and Cosmetic Rules 2011 proposed by the Union Health Ministry for subjects of clinical trials. They have suggested wider consultations before the amendments are notified.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The proposed amendments pertain to the Drugs and Cosmetics Rules, 1945 (rule 122 DAA) saying that compensation in case of injury or death during the clinical trial would be solely decided by the Ethics Committee.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
As of now, the compensation is decided by the trial sponsors, be it a pharmaceutical company, the government or an institution, in consultation with the Ethics Committee.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;ldquo;While we believe that regulation is necessary given the unchecked proliferation of clinical trials in India today, we also believe that the proposed amendment falls short of ensuring comprehensive and effective regulation,&amp;rdquo; a statement issued by Sarojini N. of Sama and Srinivasan S. of Locost said here on Thursday.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Drawing the attention of the government to the problem areas, the statement says the issues of conflict of interest within the Ethics Committee remain to be resolved as there could be institutional biases with the committee depending on who the Principal Investigator of the trial is. Importantly, many independent Ethics Committees are formed to pass protocols rather than look at them objectively.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
These are not part of any hospital but owned and operated by private commercial interest.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
While compensation will depend on injury or death on a case-by-case basis and this cannot be standardised, a wide variation in compensation decided by different Ethics Committees may not be desirable because trials may start migrating to the centres with relatively lenient Ethics Committees. The government should arrive at a specific compensation amount for death whether related or unrelated to clinical trial. For serious adverse events, an algorithm could be developed and compensation awarded based on the algorithm points.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Further, the statement says new rules have been expanded to include protocol violation and negligence of researchers, failure of investigational products, administration of placebo, adverse effects due to concomitant medication, and injury to a child in uterus.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
There needs much more discussion and elaboration as they still do not include many concerns. &amp;ldquo;The new rules will cover only permanent injury or death with no relief for even prolonged temporary injury. Also, death or injury in a trial is routinely attributed to the natural progression of the disease rather than the adverse effect of the drug being tested. There is no independent system of verification by outside experts which results in a large number of drug-related injuries and deaths being denied compensation,&amp;rdquo; says the statement.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Hindu, 13 January, 2012, http://www.thehindu.com/todays-paper/tp-national/article2797242.ece&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;amend-clinical-trial-rules-after-wider-consultations-health-activists-12545&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 12545,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 12425,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Amend clinical trial rules after wider consultations: health activists&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Hindu


&amp;nbsp;


Issues of conflict of interest within Ethics Committee remain to be resolved, they say


Public health activists and women&#039;s rights groups have raised concerns over compensation-related amendments to the Drugs and Cosmetic Rules 2011 proposed by the Union Health Ministry...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;-The Hindu&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Issues of conflict of interest within Ethics Committee remain to be resolved, they say&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Public health activists and women&#039;s rights groups have raised concerns over compensation-related amendments to the Drugs and Cosmetic Rules 2011 proposed by the Union Health Ministry for subjects of clinical trials. They have suggested wider consultations before the amendments are notified.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The proposed amendments pertain to the Drugs and Cosmetics Rules, 1945 (rule 122 DAA) saying that compensation in case of injury or death during the clinical trial would be solely decided by the Ethics Committee.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;As of now, the compensation is decided by the trial sponsors, be it a pharmaceutical company, the government or an institution, in consultation with the Ethics Committee.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;ldquo;While we believe that regulation is necessary given the unchecked proliferation of clinical trials in India today, we also believe that the proposed amendment falls short of ensuring comprehensive and effective regulation,&amp;rdquo; a statement issued by Sarojini N. of Sama and Srinivasan S. of Locost said here on Thursday.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Drawing the attention of the government to the problem areas, the statement says the issues of conflict of interest within the Ethics Committee remain to be resolved as there could be institutional biases with the committee depending on who the Principal Investigator of the trial is. Importantly, many independent Ethics Committees are formed to pass protocols rather than look at them objectively.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;These are not part of any hospital but owned and operated by private commercial interest.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;While compensation will depend on injury or death on a case-by-case basis and this cannot be standardised, a wide variation in compensation decided by different Ethics Committees may not be desirable because trials may start migrating to the centres with relatively lenient Ethics Committees. The government should arrive at a specific compensation amount for death whether related or unrelated to clinical trial. For serious adverse events, an algorithm could be developed and compensation awarded based on the algorithm points.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Further, the statement says new rules have been expanded to include protocol violation and negligence of researchers, failure of investigational products, administration of placebo, adverse effects due to concomitant medication, and injury to a child in uterus.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;There needs much more discussion and elaboration as they still do not include many concerns. &amp;ldquo;The new rules will cover only permanent injury or death with no relief for even prolonged temporary injury. Also, death or injury in a trial is routinely attributed to the natural progression of the disease rather than the adverse effect of the drug being tested. There is no independent system of verification by outside experts which results in a large number of drug-related injuries and deaths being denied compensation,&amp;rdquo; says the statement.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 12425,
	&#039;title&#039; =&gt; &#039;Amend clinical trial rules after wider consultations: health activists&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
-The Hindu
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Issues of conflict of interest within Ethics Committee remain to be resolved, they say
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Public health activists and women&#039;s rights groups have raised concerns over compensation-related amendments to the Drugs and Cosmetic Rules 2011 proposed by the Union Health Ministry for subjects of clinical trials. They have suggested wider consultations before the amendments are notified.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The proposed amendments pertain to the Drugs and Cosmetics Rules, 1945 (rule 122 DAA) saying that compensation in case of injury or death during the clinical trial would be solely decided by the Ethics Committee.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
As of now, the compensation is decided by the trial sponsors, be it a pharmaceutical company, the government or an institution, in consultation with the Ethics Committee.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;ldquo;While we believe that regulation is necessary given the unchecked proliferation of clinical trials in India today, we also believe that the proposed amendment falls short of ensuring comprehensive and effective regulation,&amp;rdquo; a statement issued by Sarojini N. of Sama and Srinivasan S. of Locost said here on Thursday.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Drawing the attention of the government to the problem areas, the statement says the issues of conflict of interest within the Ethics Committee remain to be resolved as there could be institutional biases with the committee depending on who the Principal Investigator of the trial is. Importantly, many independent Ethics Committees are formed to pass protocols rather than look at them objectively.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
These are not part of any hospital but owned and operated by private commercial interest.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
While compensation will depend on injury or death on a case-by-case basis and this cannot be standardised, a wide variation in compensation decided by different Ethics Committees may not be desirable because trials may start migrating to the centres with relatively lenient Ethics Committees. The government should arrive at a specific compensation amount for death whether related or unrelated to clinical trial. For serious adverse events, an algorithm could be developed and compensation awarded based on the algorithm points.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Further, the statement says new rules have been expanded to include protocol violation and negligence of researchers, failure of investigational products, administration of placebo, adverse effects due to concomitant medication, and injury to a child in uterus.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
There needs much more discussion and elaboration as they still do not include many concerns. &amp;ldquo;The new rules will cover only permanent injury or death with no relief for even prolonged temporary injury. Also, death or injury in a trial is routinely attributed to the natural progression of the disease rather than the adverse effect of the drug being tested. There is no independent system of verification by outside experts which results in a large number of drug-related injuries and deaths being denied compensation,&amp;rdquo; says the statement.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Hindu, 13 January, 2012, http://www.thehindu.com/todays-paper/tp-national/article2797242.ece&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;amend-clinical-trial-rules-after-wider-consultations-health-activists-12545&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 12545,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 12425
$metaTitle = &#039;LATEST NEWS UPDATES | Amend clinical trial rules after wider consultations: health activists&#039;
$metaKeywords = &#039;Health&#039;
$metaDesc = &#039;
-The Hindu


&amp;nbsp;


Issues of conflict of interest within Ethics Committee remain to be resolved, they say


Public health activists and women&#039;s rights groups have raised concerns over compensation-related amendments to the Drugs and Cosmetic Rules 2011 proposed by the Union Health Ministry...&#039;
$disp = &#039;&lt;div style=&quot;text-align: justify&quot;&gt;-The Hindu&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Issues of conflict of interest within Ethics Committee remain to be resolved, they say&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Public health activists and women&#039;s rights groups have raised concerns over compensation-related amendments to the Drugs and Cosmetic Rules 2011 proposed by the Union Health Ministry for subjects of clinical trials. They have suggested wider consultations before the amendments are notified.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The proposed amendments pertain to the Drugs and Cosmetics Rules, 1945 (rule 122 DAA) saying that compensation in case of injury or death during the clinical trial would be solely decided by the Ethics Committee.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;As of now, the compensation is decided by the trial sponsors, be it a pharmaceutical company, the government or an institution, in consultation with the Ethics Committee.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;ldquo;While we believe that regulation is necessary given the unchecked proliferation of clinical trials in India today, we also believe that the proposed amendment falls short of ensuring comprehensive and effective regulation,&amp;rdquo; a statement issued by Sarojini N. of Sama and Srinivasan S. of Locost said here on Thursday.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Drawing the attention of the government to the problem areas, the statement says the issues of conflict of interest within the Ethics Committee remain to be resolved as there could be institutional biases with the committee depending on who the Principal Investigator of the trial is. Importantly, many independent Ethics Committees are formed to pass protocols rather than look at them objectively.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;These are not part of any hospital but owned and operated by private commercial interest.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;While compensation will depend on injury or death on a case-by-case basis and this cannot be standardised, a wide variation in compensation decided by different Ethics Committees may not be desirable because trials may start migrating to the centres with relatively lenient Ethics Committees. The government should arrive at a specific compensation amount for death whether related or unrelated to clinical trial. For serious adverse events, an algorithm could be developed and compensation awarded based on the algorithm points.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Further, the statement says new rules have been expanded to include protocol violation and negligence of researchers, failure of investigational products, administration of placebo, adverse effects due to concomitant medication, and injury to a child in uterus.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;There needs much more discussion and elaboration as they still do not include many concerns. &amp;ldquo;The new rules will cover only permanent injury or death with no relief for even prolonged temporary injury. Also, death or injury in a trial is routinely attributed to the natural progression of the disease rather than the adverse effect of the drug being tested. There is no independent system of verification by outside experts which results in a large number of drug-related injuries and deaths being denied compensation,&amp;rdquo; says the statement.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/amend-clinical-trial-rules-after-wider-consultations-health-activists-12545.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Amend clinical trial rules after wider consultations: health activists | Im4change.org</title>
    <meta name="description" content="
-The Hindu


&nbsp;


Issues of conflict of interest within Ethics Committee remain to be resolved, they say


Public health activists and women's rights groups have raised concerns over compensation-related amendments to the Drugs and Cosmetic Rules 2011 proposed by the Union Health Ministry..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Amend clinical trial rules after wider consultations: health activists</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div style="text-align: justify">-The Hindu</div><div style="text-align: justify">&nbsp;</div><div style="text-align: justify">Issues of conflict of interest within Ethics Committee remain to be resolved, they say</div><div style="text-align: justify">Public health activists and women's rights groups have raised concerns over compensation-related amendments to the Drugs and Cosmetic Rules 2011 proposed by the Union Health Ministry for subjects of clinical trials. They have suggested wider consultations before the amendments are notified.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The proposed amendments pertain to the Drugs and Cosmetics Rules, 1945 (rule 122 DAA) saying that compensation in case of injury or death during the clinical trial would be solely decided by the Ethics Committee.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">As of now, the compensation is decided by the trial sponsors, be it a pharmaceutical company, the government or an institution, in consultation with the Ethics Committee.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">&ldquo;While we believe that regulation is necessary given the unchecked proliferation of clinical trials in India today, we also believe that the proposed amendment falls short of ensuring comprehensive and effective regulation,&rdquo; a statement issued by Sarojini N. of Sama and Srinivasan S. of Locost said here on Thursday.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Drawing the attention of the government to the problem areas, the statement says the issues of conflict of interest within the Ethics Committee remain to be resolved as there could be institutional biases with the committee depending on who the Principal Investigator of the trial is. Importantly, many independent Ethics Committees are formed to pass protocols rather than look at them objectively.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">These are not part of any hospital but owned and operated by private commercial interest.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">While compensation will depend on injury or death on a case-by-case basis and this cannot be standardised, a wide variation in compensation decided by different Ethics Committees may not be desirable because trials may start migrating to the centres with relatively lenient Ethics Committees. The government should arrive at a specific compensation amount for death whether related or unrelated to clinical trial. For serious adverse events, an algorithm could be developed and compensation awarded based on the algorithm points.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Further, the statement says new rules have been expanded to include protocol violation and negligence of researchers, failure of investigational products, administration of placebo, adverse effects due to concomitant medication, and injury to a child in uterus.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">There needs much more discussion and elaboration as they still do not include many concerns. &ldquo;The new rules will cover only permanent injury or death with no relief for even prolonged temporary injury. Also, death or injury in a trial is routinely attributed to the natural progression of the disease rather than the adverse effect of the drug being tested. There is no independent system of verification by outside experts which results in a large number of drug-related injuries and deaths being denied compensation,&rdquo; says the statement.</div><div style="text-align: justify"><br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6817f23d74574-trace').style.display = (document.getElementById('cakeErr6817f23d74574-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr6817f23d74574-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6817f23d74574-code').style.display = (document.getElementById('cakeErr6817f23d74574-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr6817f23d74574-context').style.display = (document.getElementById('cakeErr6817f23d74574-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr6817f23d74574-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr6817f23d74574-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 12425,
		&#039;title&#039; =&gt; &#039;Amend clinical trial rules after wider consultations: health activists&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
-The Hindu
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Issues of conflict of interest within Ethics Committee remain to be resolved, they say
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Public health activists and women&#039;s rights groups have raised concerns over compensation-related amendments to the Drugs and Cosmetic Rules 2011 proposed by the Union Health Ministry for subjects of clinical trials. They have suggested wider consultations before the amendments are notified.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The proposed amendments pertain to the Drugs and Cosmetics Rules, 1945 (rule 122 DAA) saying that compensation in case of injury or death during the clinical trial would be solely decided by the Ethics Committee.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
As of now, the compensation is decided by the trial sponsors, be it a pharmaceutical company, the government or an institution, in consultation with the Ethics Committee.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;ldquo;While we believe that regulation is necessary given the unchecked proliferation of clinical trials in India today, we also believe that the proposed amendment falls short of ensuring comprehensive and effective regulation,&amp;rdquo; a statement issued by Sarojini N. of Sama and Srinivasan S. of Locost said here on Thursday.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Drawing the attention of the government to the problem areas, the statement says the issues of conflict of interest within the Ethics Committee remain to be resolved as there could be institutional biases with the committee depending on who the Principal Investigator of the trial is. Importantly, many independent Ethics Committees are formed to pass protocols rather than look at them objectively.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
These are not part of any hospital but owned and operated by private commercial interest.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
While compensation will depend on injury or death on a case-by-case basis and this cannot be standardised, a wide variation in compensation decided by different Ethics Committees may not be desirable because trials may start migrating to the centres with relatively lenient Ethics Committees. The government should arrive at a specific compensation amount for death whether related or unrelated to clinical trial. For serious adverse events, an algorithm could be developed and compensation awarded based on the algorithm points.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Further, the statement says new rules have been expanded to include protocol violation and negligence of researchers, failure of investigational products, administration of placebo, adverse effects due to concomitant medication, and injury to a child in uterus.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
There needs much more discussion and elaboration as they still do not include many concerns. &amp;ldquo;The new rules will cover only permanent injury or death with no relief for even prolonged temporary injury. Also, death or injury in a trial is routinely attributed to the natural progression of the disease rather than the adverse effect of the drug being tested. There is no independent system of verification by outside experts which results in a large number of drug-related injuries and deaths being denied compensation,&amp;rdquo; says the statement.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Hindu, 13 January, 2012, http://www.thehindu.com/todays-paper/tp-national/article2797242.ece&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;amend-clinical-trial-rules-after-wider-consultations-health-activists-12545&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 12545,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 12425,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Amend clinical trial rules after wider consultations: health activists&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Hindu


&amp;nbsp;


Issues of conflict of interest within Ethics Committee remain to be resolved, they say


Public health activists and women&#039;s rights groups have raised concerns over compensation-related amendments to the Drugs and Cosmetic Rules 2011 proposed by the Union Health Ministry...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;-The Hindu&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Issues of conflict of interest within Ethics Committee remain to be resolved, they say&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Public health activists and women&#039;s rights groups have raised concerns over compensation-related amendments to the Drugs and Cosmetic Rules 2011 proposed by the Union Health Ministry for subjects of clinical trials. They have suggested wider consultations before the amendments are notified.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The proposed amendments pertain to the Drugs and Cosmetics Rules, 1945 (rule 122 DAA) saying that compensation in case of injury or death during the clinical trial would be solely decided by the Ethics Committee.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;As of now, the compensation is decided by the trial sponsors, be it a pharmaceutical company, the government or an institution, in consultation with the Ethics Committee.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;ldquo;While we believe that regulation is necessary given the unchecked proliferation of clinical trials in India today, we also believe that the proposed amendment falls short of ensuring comprehensive and effective regulation,&amp;rdquo; a statement issued by Sarojini N. of Sama and Srinivasan S. of Locost said here on Thursday.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Drawing the attention of the government to the problem areas, the statement says the issues of conflict of interest within the Ethics Committee remain to be resolved as there could be institutional biases with the committee depending on who the Principal Investigator of the trial is. Importantly, many independent Ethics Committees are formed to pass protocols rather than look at them objectively.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;These are not part of any hospital but owned and operated by private commercial interest.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;While compensation will depend on injury or death on a case-by-case basis and this cannot be standardised, a wide variation in compensation decided by different Ethics Committees may not be desirable because trials may start migrating to the centres with relatively lenient Ethics Committees. The government should arrive at a specific compensation amount for death whether related or unrelated to clinical trial. For serious adverse events, an algorithm could be developed and compensation awarded based on the algorithm points.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Further, the statement says new rules have been expanded to include protocol violation and negligence of researchers, failure of investigational products, administration of placebo, adverse effects due to concomitant medication, and injury to a child in uterus.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;There needs much more discussion and elaboration as they still do not include many concerns. &amp;ldquo;The new rules will cover only permanent injury or death with no relief for even prolonged temporary injury. Also, death or injury in a trial is routinely attributed to the natural progression of the disease rather than the adverse effect of the drug being tested. There is no independent system of verification by outside experts which results in a large number of drug-related injuries and deaths being denied compensation,&amp;rdquo; says the statement.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 12425,
	&#039;title&#039; =&gt; &#039;Amend clinical trial rules after wider consultations: health activists&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
-The Hindu
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Issues of conflict of interest within Ethics Committee remain to be resolved, they say
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Public health activists and women&#039;s rights groups have raised concerns over compensation-related amendments to the Drugs and Cosmetic Rules 2011 proposed by the Union Health Ministry for subjects of clinical trials. They have suggested wider consultations before the amendments are notified.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The proposed amendments pertain to the Drugs and Cosmetics Rules, 1945 (rule 122 DAA) saying that compensation in case of injury or death during the clinical trial would be solely decided by the Ethics Committee.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
As of now, the compensation is decided by the trial sponsors, be it a pharmaceutical company, the government or an institution, in consultation with the Ethics Committee.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;ldquo;While we believe that regulation is necessary given the unchecked proliferation of clinical trials in India today, we also believe that the proposed amendment falls short of ensuring comprehensive and effective regulation,&amp;rdquo; a statement issued by Sarojini N. of Sama and Srinivasan S. of Locost said here on Thursday.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Drawing the attention of the government to the problem areas, the statement says the issues of conflict of interest within the Ethics Committee remain to be resolved as there could be institutional biases with the committee depending on who the Principal Investigator of the trial is. Importantly, many independent Ethics Committees are formed to pass protocols rather than look at them objectively.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
These are not part of any hospital but owned and operated by private commercial interest.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
While compensation will depend on injury or death on a case-by-case basis and this cannot be standardised, a wide variation in compensation decided by different Ethics Committees may not be desirable because trials may start migrating to the centres with relatively lenient Ethics Committees. The government should arrive at a specific compensation amount for death whether related or unrelated to clinical trial. For serious adverse events, an algorithm could be developed and compensation awarded based on the algorithm points.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Further, the statement says new rules have been expanded to include protocol violation and negligence of researchers, failure of investigational products, administration of placebo, adverse effects due to concomitant medication, and injury to a child in uterus.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
There needs much more discussion and elaboration as they still do not include many concerns. &amp;ldquo;The new rules will cover only permanent injury or death with no relief for even prolonged temporary injury. Also, death or injury in a trial is routinely attributed to the natural progression of the disease rather than the adverse effect of the drug being tested. There is no independent system of verification by outside experts which results in a large number of drug-related injuries and deaths being denied compensation,&amp;rdquo; says the statement.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Hindu, 13 January, 2012, http://www.thehindu.com/todays-paper/tp-national/article2797242.ece&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;amend-clinical-trial-rules-after-wider-consultations-health-activists-12545&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 12545,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 12425
$metaTitle = &#039;LATEST NEWS UPDATES | Amend clinical trial rules after wider consultations: health activists&#039;
$metaKeywords = &#039;Health&#039;
$metaDesc = &#039;
-The Hindu


&amp;nbsp;


Issues of conflict of interest within Ethics Committee remain to be resolved, they say


Public health activists and women&#039;s rights groups have raised concerns over compensation-related amendments to the Drugs and Cosmetic Rules 2011 proposed by the Union Health Ministry...&#039;
$disp = &#039;&lt;div style=&quot;text-align: justify&quot;&gt;-The Hindu&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Issues of conflict of interest within Ethics Committee remain to be resolved, they say&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Public health activists and women&#039;s rights groups have raised concerns over compensation-related amendments to the Drugs and Cosmetic Rules 2011 proposed by the Union Health Ministry for subjects of clinical trials. They have suggested wider consultations before the amendments are notified.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The proposed amendments pertain to the Drugs and Cosmetics Rules, 1945 (rule 122 DAA) saying that compensation in case of injury or death during the clinical trial would be solely decided by the Ethics Committee.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;As of now, the compensation is decided by the trial sponsors, be it a pharmaceutical company, the government or an institution, in consultation with the Ethics Committee.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;ldquo;While we believe that regulation is necessary given the unchecked proliferation of clinical trials in India today, we also believe that the proposed amendment falls short of ensuring comprehensive and effective regulation,&amp;rdquo; a statement issued by Sarojini N. of Sama and Srinivasan S. of Locost said here on Thursday.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Drawing the attention of the government to the problem areas, the statement says the issues of conflict of interest within the Ethics Committee remain to be resolved as there could be institutional biases with the committee depending on who the Principal Investigator of the trial is. Importantly, many independent Ethics Committees are formed to pass protocols rather than look at them objectively.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;These are not part of any hospital but owned and operated by private commercial interest.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;While compensation will depend on injury or death on a case-by-case basis and this cannot be standardised, a wide variation in compensation decided by different Ethics Committees may not be desirable because trials may start migrating to the centres with relatively lenient Ethics Committees. The government should arrive at a specific compensation amount for death whether related or unrelated to clinical trial. For serious adverse events, an algorithm could be developed and compensation awarded based on the algorithm points.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Further, the statement says new rules have been expanded to include protocol violation and negligence of researchers, failure of investigational products, administration of placebo, adverse effects due to concomitant medication, and injury to a child in uterus.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;There needs much more discussion and elaboration as they still do not include many concerns. &amp;ldquo;The new rules will cover only permanent injury or death with no relief for even prolonged temporary injury. Also, death or injury in a trial is routinely attributed to the natural progression of the disease rather than the adverse effect of the drug being tested. There is no independent system of verification by outside experts which results in a large number of drug-related injuries and deaths being denied compensation,&amp;rdquo; says the statement.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/amend-clinical-trial-rules-after-wider-consultations-health-activists-12545.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Amend clinical trial rules after wider consultations: health activists | Im4change.org</title>
    <meta name="description" content="
-The Hindu


&nbsp;


Issues of conflict of interest within Ethics Committee remain to be resolved, they say


Public health activists and women's rights groups have raised concerns over compensation-related amendments to the Drugs and Cosmetic Rules 2011 proposed by the Union Health Ministry..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Amend clinical trial rules after wider consultations: health activists</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div style="text-align: justify">-The Hindu</div><div style="text-align: justify">&nbsp;</div><div style="text-align: justify">Issues of conflict of interest within Ethics Committee remain to be resolved, they say</div><div style="text-align: justify">Public health activists and women's rights groups have raised concerns over compensation-related amendments to the Drugs and Cosmetic Rules 2011 proposed by the Union Health Ministry for subjects of clinical trials. They have suggested wider consultations before the amendments are notified.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The proposed amendments pertain to the Drugs and Cosmetics Rules, 1945 (rule 122 DAA) saying that compensation in case of injury or death during the clinical trial would be solely decided by the Ethics Committee.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">As of now, the compensation is decided by the trial sponsors, be it a pharmaceutical company, the government or an institution, in consultation with the Ethics Committee.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">&ldquo;While we believe that regulation is necessary given the unchecked proliferation of clinical trials in India today, we also believe that the proposed amendment falls short of ensuring comprehensive and effective regulation,&rdquo; a statement issued by Sarojini N. of Sama and Srinivasan S. of Locost said here on Thursday.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Drawing the attention of the government to the problem areas, the statement says the issues of conflict of interest within the Ethics Committee remain to be resolved as there could be institutional biases with the committee depending on who the Principal Investigator of the trial is. Importantly, many independent Ethics Committees are formed to pass protocols rather than look at them objectively.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">These are not part of any hospital but owned and operated by private commercial interest.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">While compensation will depend on injury or death on a case-by-case basis and this cannot be standardised, a wide variation in compensation decided by different Ethics Committees may not be desirable because trials may start migrating to the centres with relatively lenient Ethics Committees. The government should arrive at a specific compensation amount for death whether related or unrelated to clinical trial. For serious adverse events, an algorithm could be developed and compensation awarded based on the algorithm points.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Further, the statement says new rules have been expanded to include protocol violation and negligence of researchers, failure of investigational products, administration of placebo, adverse effects due to concomitant medication, and injury to a child in uterus.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">There needs much more discussion and elaboration as they still do not include many concerns. &ldquo;The new rules will cover only permanent injury or death with no relief for even prolonged temporary injury. Also, death or injury in a trial is routinely attributed to the natural progression of the disease rather than the adverse effect of the drug being tested. There is no independent system of verification by outside experts which results in a large number of drug-related injuries and deaths being denied compensation,&rdquo; says the statement.</div><div style="text-align: justify"><br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6817f23d74574-trace').style.display = (document.getElementById('cakeErr6817f23d74574-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr6817f23d74574-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6817f23d74574-code').style.display = (document.getElementById('cakeErr6817f23d74574-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr6817f23d74574-context').style.display = (document.getElementById('cakeErr6817f23d74574-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr6817f23d74574-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr6817f23d74574-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 12425,
		&#039;title&#039; =&gt; &#039;Amend clinical trial rules after wider consultations: health activists&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
-The Hindu
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Issues of conflict of interest within Ethics Committee remain to be resolved, they say
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Public health activists and women&#039;s rights groups have raised concerns over compensation-related amendments to the Drugs and Cosmetic Rules 2011 proposed by the Union Health Ministry for subjects of clinical trials. They have suggested wider consultations before the amendments are notified.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The proposed amendments pertain to the Drugs and Cosmetics Rules, 1945 (rule 122 DAA) saying that compensation in case of injury or death during the clinical trial would be solely decided by the Ethics Committee.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
As of now, the compensation is decided by the trial sponsors, be it a pharmaceutical company, the government or an institution, in consultation with the Ethics Committee.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;ldquo;While we believe that regulation is necessary given the unchecked proliferation of clinical trials in India today, we also believe that the proposed amendment falls short of ensuring comprehensive and effective regulation,&amp;rdquo; a statement issued by Sarojini N. of Sama and Srinivasan S. of Locost said here on Thursday.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Drawing the attention of the government to the problem areas, the statement says the issues of conflict of interest within the Ethics Committee remain to be resolved as there could be institutional biases with the committee depending on who the Principal Investigator of the trial is. Importantly, many independent Ethics Committees are formed to pass protocols rather than look at them objectively.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
These are not part of any hospital but owned and operated by private commercial interest.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
While compensation will depend on injury or death on a case-by-case basis and this cannot be standardised, a wide variation in compensation decided by different Ethics Committees may not be desirable because trials may start migrating to the centres with relatively lenient Ethics Committees. The government should arrive at a specific compensation amount for death whether related or unrelated to clinical trial. For serious adverse events, an algorithm could be developed and compensation awarded based on the algorithm points.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Further, the statement says new rules have been expanded to include protocol violation and negligence of researchers, failure of investigational products, administration of placebo, adverse effects due to concomitant medication, and injury to a child in uterus.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
There needs much more discussion and elaboration as they still do not include many concerns. &amp;ldquo;The new rules will cover only permanent injury or death with no relief for even prolonged temporary injury. Also, death or injury in a trial is routinely attributed to the natural progression of the disease rather than the adverse effect of the drug being tested. There is no independent system of verification by outside experts which results in a large number of drug-related injuries and deaths being denied compensation,&amp;rdquo; says the statement.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Hindu, 13 January, 2012, http://www.thehindu.com/todays-paper/tp-national/article2797242.ece&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;amend-clinical-trial-rules-after-wider-consultations-health-activists-12545&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 12545,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 12425,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Amend clinical trial rules after wider consultations: health activists&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Hindu


&amp;nbsp;


Issues of conflict of interest within Ethics Committee remain to be resolved, they say


Public health activists and women&#039;s rights groups have raised concerns over compensation-related amendments to the Drugs and Cosmetic Rules 2011 proposed by the Union Health Ministry...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;-The Hindu&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Issues of conflict of interest within Ethics Committee remain to be resolved, they say&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Public health activists and women&#039;s rights groups have raised concerns over compensation-related amendments to the Drugs and Cosmetic Rules 2011 proposed by the Union Health Ministry for subjects of clinical trials. They have suggested wider consultations before the amendments are notified.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The proposed amendments pertain to the Drugs and Cosmetics Rules, 1945 (rule 122 DAA) saying that compensation in case of injury or death during the clinical trial would be solely decided by the Ethics Committee.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;As of now, the compensation is decided by the trial sponsors, be it a pharmaceutical company, the government or an institution, in consultation with the Ethics Committee.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;ldquo;While we believe that regulation is necessary given the unchecked proliferation of clinical trials in India today, we also believe that the proposed amendment falls short of ensuring comprehensive and effective regulation,&amp;rdquo; a statement issued by Sarojini N. of Sama and Srinivasan S. of Locost said here on Thursday.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Drawing the attention of the government to the problem areas, the statement says the issues of conflict of interest within the Ethics Committee remain to be resolved as there could be institutional biases with the committee depending on who the Principal Investigator of the trial is. Importantly, many independent Ethics Committees are formed to pass protocols rather than look at them objectively.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;These are not part of any hospital but owned and operated by private commercial interest.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;While compensation will depend on injury or death on a case-by-case basis and this cannot be standardised, a wide variation in compensation decided by different Ethics Committees may not be desirable because trials may start migrating to the centres with relatively lenient Ethics Committees. The government should arrive at a specific compensation amount for death whether related or unrelated to clinical trial. For serious adverse events, an algorithm could be developed and compensation awarded based on the algorithm points.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Further, the statement says new rules have been expanded to include protocol violation and negligence of researchers, failure of investigational products, administration of placebo, adverse effects due to concomitant medication, and injury to a child in uterus.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;There needs much more discussion and elaboration as they still do not include many concerns. &amp;ldquo;The new rules will cover only permanent injury or death with no relief for even prolonged temporary injury. Also, death or injury in a trial is routinely attributed to the natural progression of the disease rather than the adverse effect of the drug being tested. There is no independent system of verification by outside experts which results in a large number of drug-related injuries and deaths being denied compensation,&amp;rdquo; says the statement.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 12425,
	&#039;title&#039; =&gt; &#039;Amend clinical trial rules after wider consultations: health activists&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
-The Hindu
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Issues of conflict of interest within Ethics Committee remain to be resolved, they say
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Public health activists and women&#039;s rights groups have raised concerns over compensation-related amendments to the Drugs and Cosmetic Rules 2011 proposed by the Union Health Ministry for subjects of clinical trials. They have suggested wider consultations before the amendments are notified.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The proposed amendments pertain to the Drugs and Cosmetics Rules, 1945 (rule 122 DAA) saying that compensation in case of injury or death during the clinical trial would be solely decided by the Ethics Committee.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
As of now, the compensation is decided by the trial sponsors, be it a pharmaceutical company, the government or an institution, in consultation with the Ethics Committee.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;ldquo;While we believe that regulation is necessary given the unchecked proliferation of clinical trials in India today, we also believe that the proposed amendment falls short of ensuring comprehensive and effective regulation,&amp;rdquo; a statement issued by Sarojini N. of Sama and Srinivasan S. of Locost said here on Thursday.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Drawing the attention of the government to the problem areas, the statement says the issues of conflict of interest within the Ethics Committee remain to be resolved as there could be institutional biases with the committee depending on who the Principal Investigator of the trial is. Importantly, many independent Ethics Committees are formed to pass protocols rather than look at them objectively.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
These are not part of any hospital but owned and operated by private commercial interest.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
While compensation will depend on injury or death on a case-by-case basis and this cannot be standardised, a wide variation in compensation decided by different Ethics Committees may not be desirable because trials may start migrating to the centres with relatively lenient Ethics Committees. The government should arrive at a specific compensation amount for death whether related or unrelated to clinical trial. For serious adverse events, an algorithm could be developed and compensation awarded based on the algorithm points.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Further, the statement says new rules have been expanded to include protocol violation and negligence of researchers, failure of investigational products, administration of placebo, adverse effects due to concomitant medication, and injury to a child in uterus.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
There needs much more discussion and elaboration as they still do not include many concerns. &amp;ldquo;The new rules will cover only permanent injury or death with no relief for even prolonged temporary injury. Also, death or injury in a trial is routinely attributed to the natural progression of the disease rather than the adverse effect of the drug being tested. There is no independent system of verification by outside experts which results in a large number of drug-related injuries and deaths being denied compensation,&amp;rdquo; says the statement.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Hindu, 13 January, 2012, http://www.thehindu.com/todays-paper/tp-national/article2797242.ece&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;amend-clinical-trial-rules-after-wider-consultations-health-activists-12545&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 12545,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 12425
$metaTitle = &#039;LATEST NEWS UPDATES | Amend clinical trial rules after wider consultations: health activists&#039;
$metaKeywords = &#039;Health&#039;
$metaDesc = &#039;
-The Hindu


&amp;nbsp;


Issues of conflict of interest within Ethics Committee remain to be resolved, they say


Public health activists and women&#039;s rights groups have raised concerns over compensation-related amendments to the Drugs and Cosmetic Rules 2011 proposed by the Union Health Ministry...&#039;
$disp = &#039;&lt;div style=&quot;text-align: justify&quot;&gt;-The Hindu&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Issues of conflict of interest within Ethics Committee remain to be resolved, they say&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Public health activists and women&#039;s rights groups have raised concerns over compensation-related amendments to the Drugs and Cosmetic Rules 2011 proposed by the Union Health Ministry for subjects of clinical trials. They have suggested wider consultations before the amendments are notified.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The proposed amendments pertain to the Drugs and Cosmetics Rules, 1945 (rule 122 DAA) saying that compensation in case of injury or death during the clinical trial would be solely decided by the Ethics Committee.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;As of now, the compensation is decided by the trial sponsors, be it a pharmaceutical company, the government or an institution, in consultation with the Ethics Committee.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;ldquo;While we believe that regulation is necessary given the unchecked proliferation of clinical trials in India today, we also believe that the proposed amendment falls short of ensuring comprehensive and effective regulation,&amp;rdquo; a statement issued by Sarojini N. of Sama and Srinivasan S. of Locost said here on Thursday.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Drawing the attention of the government to the problem areas, the statement says the issues of conflict of interest within the Ethics Committee remain to be resolved as there could be institutional biases with the committee depending on who the Principal Investigator of the trial is. Importantly, many independent Ethics Committees are formed to pass protocols rather than look at them objectively.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;These are not part of any hospital but owned and operated by private commercial interest.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;While compensation will depend on injury or death on a case-by-case basis and this cannot be standardised, a wide variation in compensation decided by different Ethics Committees may not be desirable because trials may start migrating to the centres with relatively lenient Ethics Committees. The government should arrive at a specific compensation amount for death whether related or unrelated to clinical trial. For serious adverse events, an algorithm could be developed and compensation awarded based on the algorithm points.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Further, the statement says new rules have been expanded to include protocol violation and negligence of researchers, failure of investigational products, administration of placebo, adverse effects due to concomitant medication, and injury to a child in uterus.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;There needs much more discussion and elaboration as they still do not include many concerns. &amp;ldquo;The new rules will cover only permanent injury or death with no relief for even prolonged temporary injury. Also, death or injury in a trial is routinely attributed to the natural progression of the disease rather than the adverse effect of the drug being tested. There is no independent system of verification by outside experts which results in a large number of drug-related injuries and deaths being denied compensation,&amp;rdquo; says the statement.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/amend-clinical-trial-rules-after-wider-consultations-health-activists-12545.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Amend clinical trial rules after wider consultations: health activists | Im4change.org</title>
    <meta name="description" content="
-The Hindu


&nbsp;


Issues of conflict of interest within Ethics Committee remain to be resolved, they say


Public health activists and women's rights groups have raised concerns over compensation-related amendments to the Drugs and Cosmetic Rules 2011 proposed by the Union Health Ministry..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Amend clinical trial rules after wider consultations: health activists</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div style="text-align: justify">-The Hindu</div><div style="text-align: justify">&nbsp;</div><div style="text-align: justify">Issues of conflict of interest within Ethics Committee remain to be resolved, they say</div><div style="text-align: justify">Public health activists and women's rights groups have raised concerns over compensation-related amendments to the Drugs and Cosmetic Rules 2011 proposed by the Union Health Ministry for subjects of clinical trials. They have suggested wider consultations before the amendments are notified.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The proposed amendments pertain to the Drugs and Cosmetics Rules, 1945 (rule 122 DAA) saying that compensation in case of injury or death during the clinical trial would be solely decided by the Ethics Committee.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">As of now, the compensation is decided by the trial sponsors, be it a pharmaceutical company, the government or an institution, in consultation with the Ethics Committee.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">&ldquo;While we believe that regulation is necessary given the unchecked proliferation of clinical trials in India today, we also believe that the proposed amendment falls short of ensuring comprehensive and effective regulation,&rdquo; a statement issued by Sarojini N. of Sama and Srinivasan S. of Locost said here on Thursday.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Drawing the attention of the government to the problem areas, the statement says the issues of conflict of interest within the Ethics Committee remain to be resolved as there could be institutional biases with the committee depending on who the Principal Investigator of the trial is. Importantly, many independent Ethics Committees are formed to pass protocols rather than look at them objectively.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">These are not part of any hospital but owned and operated by private commercial interest.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">While compensation will depend on injury or death on a case-by-case basis and this cannot be standardised, a wide variation in compensation decided by different Ethics Committees may not be desirable because trials may start migrating to the centres with relatively lenient Ethics Committees. The government should arrive at a specific compensation amount for death whether related or unrelated to clinical trial. For serious adverse events, an algorithm could be developed and compensation awarded based on the algorithm points.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Further, the statement says new rules have been expanded to include protocol violation and negligence of researchers, failure of investigational products, administration of placebo, adverse effects due to concomitant medication, and injury to a child in uterus.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">There needs much more discussion and elaboration as they still do not include many concerns. &ldquo;The new rules will cover only permanent injury or death with no relief for even prolonged temporary injury. Also, death or injury in a trial is routinely attributed to the natural progression of the disease rather than the adverse effect of the drug being tested. There is no independent system of verification by outside experts which results in a large number of drug-related injuries and deaths being denied compensation,&rdquo; says the statement.</div><div style="text-align: justify"><br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 12425,
		'title' => 'Amend clinical trial rules after wider consultations: health activists',
		'subheading' => '',
		'description' => '<div style="text-align: justify">
-The Hindu
</div>
<div style="text-align: justify">
&nbsp;
</div>
<div style="text-align: justify">
Issues of conflict of interest within Ethics Committee remain to be resolved, they say
</div>
<div style="text-align: justify">
Public health activists and women's rights groups have raised concerns over compensation-related amendments to the Drugs and Cosmetic Rules 2011 proposed by the Union Health Ministry for subjects of clinical trials. They have suggested wider consultations before the amendments are notified.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
The proposed amendments pertain to the Drugs and Cosmetics Rules, 1945 (rule 122 DAA) saying that compensation in case of injury or death during the clinical trial would be solely decided by the Ethics Committee.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
As of now, the compensation is decided by the trial sponsors, be it a pharmaceutical company, the government or an institution, in consultation with the Ethics Committee.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
&ldquo;While we believe that regulation is necessary given the unchecked proliferation of clinical trials in India today, we also believe that the proposed amendment falls short of ensuring comprehensive and effective regulation,&rdquo; a statement issued by Sarojini N. of Sama and Srinivasan S. of Locost said here on Thursday.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
Drawing the attention of the government to the problem areas, the statement says the issues of conflict of interest within the Ethics Committee remain to be resolved as there could be institutional biases with the committee depending on who the Principal Investigator of the trial is. Importantly, many independent Ethics Committees are formed to pass protocols rather than look at them objectively.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
These are not part of any hospital but owned and operated by private commercial interest.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
While compensation will depend on injury or death on a case-by-case basis and this cannot be standardised, a wide variation in compensation decided by different Ethics Committees may not be desirable because trials may start migrating to the centres with relatively lenient Ethics Committees. The government should arrive at a specific compensation amount for death whether related or unrelated to clinical trial. For serious adverse events, an algorithm could be developed and compensation awarded based on the algorithm points.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
Further, the statement says new rules have been expanded to include protocol violation and negligence of researchers, failure of investigational products, administration of placebo, adverse effects due to concomitant medication, and injury to a child in uterus.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
There needs much more discussion and elaboration as they still do not include many concerns. &ldquo;The new rules will cover only permanent injury or death with no relief for even prolonged temporary injury. Also, death or injury in a trial is routinely attributed to the natural progression of the disease rather than the adverse effect of the drug being tested. There is no independent system of verification by outside experts which results in a large number of drug-related injuries and deaths being denied compensation,&rdquo; says the statement.
</div>
<div style="text-align: justify">
<br />
</div>',
		'credit_writer' => 'The Hindu, 13 January, 2012, http://www.thehindu.com/todays-paper/tp-national/article2797242.ece',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'amend-clinical-trial-rules-after-wider-consultations-health-activists-12545',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 12545,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 12425,
	'metaTitle' => 'LATEST NEWS UPDATES | Amend clinical trial rules after wider consultations: health activists',
	'metaKeywords' => 'Health',
	'metaDesc' => '
-The Hindu


&nbsp;


Issues of conflict of interest within Ethics Committee remain to be resolved, they say


Public health activists and women's rights groups have raised concerns over compensation-related amendments to the Drugs and Cosmetic Rules 2011 proposed by the Union Health Ministry...',
	'disp' => '<div style="text-align: justify">-The Hindu</div><div style="text-align: justify">&nbsp;</div><div style="text-align: justify">Issues of conflict of interest within Ethics Committee remain to be resolved, they say</div><div style="text-align: justify">Public health activists and women's rights groups have raised concerns over compensation-related amendments to the Drugs and Cosmetic Rules 2011 proposed by the Union Health Ministry for subjects of clinical trials. They have suggested wider consultations before the amendments are notified.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The proposed amendments pertain to the Drugs and Cosmetics Rules, 1945 (rule 122 DAA) saying that compensation in case of injury or death during the clinical trial would be solely decided by the Ethics Committee.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">As of now, the compensation is decided by the trial sponsors, be it a pharmaceutical company, the government or an institution, in consultation with the Ethics Committee.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">&ldquo;While we believe that regulation is necessary given the unchecked proliferation of clinical trials in India today, we also believe that the proposed amendment falls short of ensuring comprehensive and effective regulation,&rdquo; a statement issued by Sarojini N. of Sama and Srinivasan S. of Locost said here on Thursday.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Drawing the attention of the government to the problem areas, the statement says the issues of conflict of interest within the Ethics Committee remain to be resolved as there could be institutional biases with the committee depending on who the Principal Investigator of the trial is. Importantly, many independent Ethics Committees are formed to pass protocols rather than look at them objectively.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">These are not part of any hospital but owned and operated by private commercial interest.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">While compensation will depend on injury or death on a case-by-case basis and this cannot be standardised, a wide variation in compensation decided by different Ethics Committees may not be desirable because trials may start migrating to the centres with relatively lenient Ethics Committees. The government should arrive at a specific compensation amount for death whether related or unrelated to clinical trial. For serious adverse events, an algorithm could be developed and compensation awarded based on the algorithm points.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Further, the statement says new rules have been expanded to include protocol violation and negligence of researchers, failure of investigational products, administration of placebo, adverse effects due to concomitant medication, and injury to a child in uterus.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">There needs much more discussion and elaboration as they still do not include many concerns. &ldquo;The new rules will cover only permanent injury or death with no relief for even prolonged temporary injury. Also, death or injury in a trial is routinely attributed to the natural progression of the disease rather than the adverse effect of the drug being tested. There is no independent system of verification by outside experts which results in a large number of drug-related injuries and deaths being denied compensation,&rdquo; says the statement.</div><div style="text-align: justify"><br /></div>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 12425,
	'title' => 'Amend clinical trial rules after wider consultations: health activists',
	'subheading' => '',
	'description' => '<div style="text-align: justify">
-The Hindu
</div>
<div style="text-align: justify">
&nbsp;
</div>
<div style="text-align: justify">
Issues of conflict of interest within Ethics Committee remain to be resolved, they say
</div>
<div style="text-align: justify">
Public health activists and women's rights groups have raised concerns over compensation-related amendments to the Drugs and Cosmetic Rules 2011 proposed by the Union Health Ministry for subjects of clinical trials. They have suggested wider consultations before the amendments are notified.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
The proposed amendments pertain to the Drugs and Cosmetics Rules, 1945 (rule 122 DAA) saying that compensation in case of injury or death during the clinical trial would be solely decided by the Ethics Committee.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
As of now, the compensation is decided by the trial sponsors, be it a pharmaceutical company, the government or an institution, in consultation with the Ethics Committee.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
&ldquo;While we believe that regulation is necessary given the unchecked proliferation of clinical trials in India today, we also believe that the proposed amendment falls short of ensuring comprehensive and effective regulation,&rdquo; a statement issued by Sarojini N. of Sama and Srinivasan S. of Locost said here on Thursday.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
Drawing the attention of the government to the problem areas, the statement says the issues of conflict of interest within the Ethics Committee remain to be resolved as there could be institutional biases with the committee depending on who the Principal Investigator of the trial is. Importantly, many independent Ethics Committees are formed to pass protocols rather than look at them objectively.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
These are not part of any hospital but owned and operated by private commercial interest.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
While compensation will depend on injury or death on a case-by-case basis and this cannot be standardised, a wide variation in compensation decided by different Ethics Committees may not be desirable because trials may start migrating to the centres with relatively lenient Ethics Committees. The government should arrive at a specific compensation amount for death whether related or unrelated to clinical trial. For serious adverse events, an algorithm could be developed and compensation awarded based on the algorithm points.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
Further, the statement says new rules have been expanded to include protocol violation and negligence of researchers, failure of investigational products, administration of placebo, adverse effects due to concomitant medication, and injury to a child in uterus.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
There needs much more discussion and elaboration as they still do not include many concerns. &ldquo;The new rules will cover only permanent injury or death with no relief for even prolonged temporary injury. Also, death or injury in a trial is routinely attributed to the natural progression of the disease rather than the adverse effect of the drug being tested. There is no independent system of verification by outside experts which results in a large number of drug-related injuries and deaths being denied compensation,&rdquo; says the statement.
</div>
<div style="text-align: justify">
<br />
</div>',
	'credit_writer' => 'The Hindu, 13 January, 2012, http://www.thehindu.com/todays-paper/tp-national/article2797242.ece',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'amend-clinical-trial-rules-after-wider-consultations-health-activists-12545',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 12545,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 12425
$metaTitle = 'LATEST NEWS UPDATES | Amend clinical trial rules after wider consultations: health activists'
$metaKeywords = 'Health'
$metaDesc = '
-The Hindu


&nbsp;


Issues of conflict of interest within Ethics Committee remain to be resolved, they say


Public health activists and women's rights groups have raised concerns over compensation-related amendments to the Drugs and Cosmetic Rules 2011 proposed by the Union Health Ministry...'
$disp = '<div style="text-align: justify">-The Hindu</div><div style="text-align: justify">&nbsp;</div><div style="text-align: justify">Issues of conflict of interest within Ethics Committee remain to be resolved, they say</div><div style="text-align: justify">Public health activists and women's rights groups have raised concerns over compensation-related amendments to the Drugs and Cosmetic Rules 2011 proposed by the Union Health Ministry for subjects of clinical trials. They have suggested wider consultations before the amendments are notified.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The proposed amendments pertain to the Drugs and Cosmetics Rules, 1945 (rule 122 DAA) saying that compensation in case of injury or death during the clinical trial would be solely decided by the Ethics Committee.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">As of now, the compensation is decided by the trial sponsors, be it a pharmaceutical company, the government or an institution, in consultation with the Ethics Committee.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">&ldquo;While we believe that regulation is necessary given the unchecked proliferation of clinical trials in India today, we also believe that the proposed amendment falls short of ensuring comprehensive and effective regulation,&rdquo; a statement issued by Sarojini N. of Sama and Srinivasan S. of Locost said here on Thursday.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Drawing the attention of the government to the problem areas, the statement says the issues of conflict of interest within the Ethics Committee remain to be resolved as there could be institutional biases with the committee depending on who the Principal Investigator of the trial is. Importantly, many independent Ethics Committees are formed to pass protocols rather than look at them objectively.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">These are not part of any hospital but owned and operated by private commercial interest.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">While compensation will depend on injury or death on a case-by-case basis and this cannot be standardised, a wide variation in compensation decided by different Ethics Committees may not be desirable because trials may start migrating to the centres with relatively lenient Ethics Committees. The government should arrive at a specific compensation amount for death whether related or unrelated to clinical trial. For serious adverse events, an algorithm could be developed and compensation awarded based on the algorithm points.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Further, the statement says new rules have been expanded to include protocol violation and negligence of researchers, failure of investigational products, administration of placebo, adverse effects due to concomitant medication, and injury to a child in uterus.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">There needs much more discussion and elaboration as they still do not include many concerns. &ldquo;The new rules will cover only permanent injury or death with no relief for even prolonged temporary injury. Also, death or injury in a trial is routinely attributed to the natural progression of the disease rather than the adverse effect of the drug being tested. There is no independent system of verification by outside experts which results in a large number of drug-related injuries and deaths being denied compensation,&rdquo; says the statement.</div><div style="text-align: justify"><br /></div>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

Amend clinical trial rules after wider consultations: health activists

-The Hindu   Issues of conflict of interest within Ethics Committee remain to be resolved, they say Public health activists and women's rights groups have raised concerns over compensation-related amendments to the Drugs and Cosmetic Rules 2011 proposed by the Union Health Ministry for subjects of clinical trials. They have suggested wider consultations before the amendments are notified. The proposed amendments pertain to the Drugs and Cosmetics Rules, 1945 (rule 122 DAA) saying that compensation in case of injury or death during the clinical trial would be solely decided by the Ethics Committee. As of now, the compensation is decided by the trial sponsors, be it a pharmaceutical company, the government or an institution, in consultation with the Ethics Committee. “While we believe that regulation is necessary given the unchecked proliferation of clinical trials in India today, we also believe that the proposed amendment falls short of ensuring comprehensive and effective regulation,” a statement issued by Sarojini N. of Sama and Srinivasan S. of Locost said here on Thursday. Drawing the attention of the government to the problem areas, the statement says the issues of conflict of interest within the Ethics Committee remain to be resolved as there could be institutional biases with the committee depending on who the Principal Investigator of the trial is. Importantly, many independent Ethics Committees are formed to pass protocols rather than look at them objectively. These are not part of any hospital but owned and operated by private commercial interest. While compensation will depend on injury or death on a case-by-case basis and this cannot be standardised, a wide variation in compensation decided by different Ethics Committees may not be desirable because trials may start migrating to the centres with relatively lenient Ethics Committees. The government should arrive at a specific compensation amount for death whether related or unrelated to clinical trial. For serious adverse events, an algorithm could be developed and compensation awarded based on the algorithm points. Further, the statement says new rules have been expanded to include protocol violation and negligence of researchers, failure of investigational products, administration of placebo, adverse effects due to concomitant medication, and injury to a child in uterus. There needs much more discussion and elaboration as they still do not include many concerns. “The new rules will cover only permanent injury or death with no relief for even prolonged temporary injury. Also, death or injury in a trial is routinely attributed to the natural progression of the disease rather than the adverse effect of the drug being tested. There is no independent system of verification by outside experts which results in a large number of drug-related injuries and deaths being denied compensation,” says the statement.